|
05/21/2013 09:15:53
Index/Home
Cryme Trainer (moved)
Non-HLA-linked Diseases
Hurricane Sandy and Mold-Related
illnesses (like LYMErix and Lyme Disease, and CFIDS/FM).
=======
References for
psychotropics-induced brain damage
Older data on the incurability of
Relapsing Fever
1986, McSweegan trashes Navy
for $$$ for ALDF.com
1988, Dattwyler & about
immune-suppressing, seronegative Lyme
1990, CDC: "Diagnose Lyme
as if it was Relapsing Fever."
Allen Steere
"NeuroLyme won't test positive," 1990.
1992, CDC officer Allen
Steere falsifies testing in Europe
1992, CDC
patents with SmithKline show 2 kinds of Lyme
Compare the 2 kinds of
Lyme in the RICO complaint
1994, CDC's Dearborn Booklet
.pdf
CDC's invitation to
participate in Dearborn .pdf
Igenex, Harris,
Dearborn .pdf
Evidence
Lyme criminals knew LYMErix produced the same "multisystem disease" as "Chronic
Lyme"
LYMErix Damage Coverup
(short)
120302 NIH Treatments
1998, CIA Oilmen & Israelis plan to overthrow
Saddam for the oil.
Bush/Gore Oil/War-(Oct,2000)
Bush's own explainer (Oct
2000) re:
Iraq Oil
| |
BRITISH_PSYCHIATRY- How Psychopaths Running the Asylum began.

http://www.youtube.com/watch?v=zHT0S1KawJI&feature=related
I am a BigPharma chemist, so you can
trust I am revealing all truisms about these "medications"--
The science which shows that all
psychotropics are brain damaging
Download it for the best
copy: Psychiatric_MumboJumbo.wmv


Click to enlarge and then click again to enlarge further.
"Medications for psychiatric disorders can
be both the cause of delirium and exacerbate or contribute to delirium from
other causes."- The American Psychiatric Association.
The above means Ely Lilly certainly
knew they were committing a crime (malpractice) by recommending Zyprexa
for dementia patients (or CNS depressants for the CNS depressed as
demonstrated by scientifically valid relapsing and remitting brain
SPECT scans in response to the IV drug ceftriaxone), since the American Psychiatric Association's own
guidelines say central nervous system depressants make the delirium or
dementia worse.
=================================================
Ben Bunney
changed his website (the original was captured below) after I made this public, but this data could be
subpoenaed.
Yale's Psych Chair's, Benjamin Bunney's, expertise is psychotropics-induced brain damage:
"Biological Abnormalities of Movement Disorders"
DCF's and Yale's
Psychotropics guinea pigs
OLD BEN BUNNEY WEBPAGE:
------------------------------------------------------------------------------------------------------------------------


The
Program

Research
Endeavors

Faculty

Basic

Neuroscience

Clinical

Neuroscience

Current
Residents

Application Procedures

How to
Contact Us


Yale University School of Medicine 333 Cedar Street New Haven, CT 06510 USA
 Directory Assistance (203) 432-4771
 Office of Public Affairs (203) 432-1333

 |
|
|
    
Clinical and Basic Neuroscience Research Training Program in Psychiatry
Basic Neuroscience Faculty
|
Benjamin Stephenson Bunney, MD |

 |
|
|
Benjamin Stephenson Bunney, MD
Charles BG Murphy Professor and Chairman
Department Of Psychiatry
Professor of Pharmacology
25 Park Street, Room 619

Phone:(203) 785-6396
Fax:(203) 785-6196
Email:benjamin.bunney@yale.edu

|
Education
 |
BA, New York University, 1960
 |
 |
MD, New York University School of Medicine, 1964
|
Research Interests
The motivating force in Dr. Bunney's laboratory is an interest in the
biological abnormalities underlying psychosis and movement disorders
(e.g. Parkinson's Disease). His studies focus on the elucidation of
mechanisms involved in the control of dopamine systems in the brain and
their regulation by psychotropic drugs, employing neurophysiological,
neurochemical and anatomical techniques.
Expertise
 |
Neurophysiology of Midbrain Dopamine Systems
 |
 |
Pathogenesis of Psychosis
 |
 |
Biological Abnormalities of Movement Disorders
|
Achievements and Honors
 |
Efron Award for Research, ACNP, 1983
 |
 |
Lieber Prize, NARSAD, 1987
 |
 |
Merit Award, NIMH, 1990-2000
 |
 |
Chairman, Board of Scientific Counselors, NIMH, 1989-1994
 |
 |
Institute of Medicine, NAS, 1993
|
Publications of Note
 |
Shi, W.X. and Bunney, B.S. Antipsychotic drug-induced depolarization
inactivation of dopaminergic neurons: evidence, mechanism, and
significance. In: CNS Neurotransmitters and Neuromodulators: Dopamine
(Ed. T.W. Stone), CRC Press, Inc., Boca Raton, pp. 121-130, 1996.
 |
 |
Shi, W.X., Smith, P.L., Pun, C.L., Millet, B. and Bunney, B.S. D1 and
D2 interaction in feedback control of midbrain dopamine neurons, The
Journal of Neuroscience, 17(20): 7988-7994, 1997.
 |
 |
Shi, W.X., Zheng, P., Liang, X.F. and Bunney, B.S. Characterization of
dopamine-induced depolarization of prefrontal cortical neurons,
Synapse, 26: 415-422, 1997.
|
(select one below)

A.....B.....C.....D

E.....F.....G.....H

I.....J.....K.....L

M.....
N.....O.....P

Q.....R.....S.....T

U....V.....W.....X

Y.....Z |

 |

Last
modified: October 7, 1999

    



Copyright ©1999 Yale University School of Medicine, Department of
Psychiatry. All rights reserved. Comments or suggestions to the
site editor.

Home
URL: http://info.med.yale.edu/ysm
 |
|